产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 17011720 | TC-H 106 | 937039-45-7 | 98% |  |
| TC-H 106, 也称为Pimelic Diphenylamide 106, 是一种一类HDAC抑制剂，对II类 | ||||
| 17011719 | TAS-301 | 193620-69-8 | 98% |  |
| TAS-301是一种有效的、选择性的球囊冠状动脉过度拉伸损伤后的收 | ||||
| 17011718 | TAS-103 | 174634-08-3 | 98% |  |
| TAS-103,也称为BMS-247615, 是一种喹啉衍生物，在小鼠和人体肿瘤模型 | ||||
| 17011717 | Talabostat甲磺酸盐 | 150080-09-4 | 98% |  |
| Talabostat, 也称为PT-100,具有抗肿瘤和造血作用的二肽肽酶抑制剂。 | ||||
| 17011716 | TAK-659盐酸盐 | 1312691-41-0 | 98% |  |
| TAK-659是脾脏酪氨酸激酶(syk)的抑制剂，具有潜在的抗炎、免疫和抗 | ||||
| 17011715 | TAK-285 | 871026-44-7 | 98% |  |
| TAK-285是一种新的双erbB蛋白激酶抑制剂，专门针对人类表皮生长因 | ||||
| 17109008 | 盐酸坦索罗辛 | 106463-17-6 | 98% |  |
| 盐酸坦索罗辛是一个强有力的和选择性α1a肾上腺素能受体拮抗剂 | ||||
| 16122840 | T-0901317 | 293754-55-9 | 98% |  |
| T-0901317, also known as T-1317; TO-091317; TO 901317, is a liver X receptor (LXR) ag | ||||
| 16122728 | Terazosin | 63074-08-8 | 98% |  |
| Terazosin is a selective alpha-1 antagonist used for treatment of symptoms of an enla | ||||
| 16122718 | Tubercidin | 69-33-0 | 98% |  |
| Tubercidin, an adenosine analogue, is a nucleoside antibiotic. It is incorporated int | ||||
| 6111515 | TPO agonist 1 | 1033040-23-1 | 98% |  |
| TPO agonist 1 can increase production of platelets by stimulating the TPO receptor in | ||||
| 61118 | TY-52156 | 934369-14-9 | 98% | |
| TY-52156 is a potent S1P3 receptor antagonist in a competitive manner, and the Ki val | ||||
| 61117 | TCS-OX2-29 | 372523-75-6 | 98% |  |
| TCS-OX2-29 is a potent and selective OX2 receptor antagonist with IC50 of 40 nM. Disp | ||||
| 6111013 | THZ1 | 1604810-83-4 | 98% | |
| THZ1 is a novel selective and potent covalent CDK7 inhibitor with IC50(binding affini | ||||
| 611934 | TZ9 | 1002789-86-7 | 98% | |
| TZ9 is a novel inhibitor of Rad6 ubiquitin conjugating enzyme(E2 enzyme); inhibits MD | ||||
| 611926 | THZ1-R | 1621523-07-6 | 98% | |
| THZ1-R is a non-cysteine reactive analog, which displays diminished activity for CDK7 | ||||
| 611925 | THZ1 Hydrochloride | 98% |  | |
| THZ1 Hcl is a novel selective and potent covalent CDK7 inhibitor with IC50(binding af | ||||
| 611905 | TGR-1202 hydrochloride | 1532533-78-0 | 98% | |
| TGR-1202 hydrochloride is an orally available, next generation PI3Kdelta inhibitor, i | ||||
| 611904 | TGR-1202 | 1532533-67-7 | 98% |  |
| TGR-1202 is an orally available, next generation PI3Kdelta inhibitor, inhibits PI3K a | ||||
| 161009029 | TDZD-8 | 327036-89-5 | 98% by HPLC |  |
| TDZD-8 protects the brain against I/R injury by inhibiting GSK-3beta activity. TDZD-8 | ||||
| 9028 | Tideglusib | 865854-05-3 | 98% |  |
| Tideglusib protects neural stem cells against NMDA receptor overactivation. Tideglusi | ||||
| 161009027 | TWS-119 | 601514-19-6 (free base); 1507095-58-0 (2 TFA salt) | 98% by HPLC |  |
| TWS119 could activate Wnt/-catenin pathway and up-regulate the expression of CD62L in | ||||
| 161009022 | Triciribine | 35943-35-2 | 98% by HPLC |  |
| Triciribine inhibits the phosphorylation, activation, and signalling of Akt-1, -2, an | ||||
| 161009006 | Tacrolimus | 104987-11-3 | 98% by HPLC |  |
| It is also used in a topical preparation in the treatment of atopic dermatitis (eczem | ||||
| 160926017 | TG100713 | 925705-73-3 | 98% by HPLC |  |
| TG100713 is an inhibitor of PI3-kinase (IC50 values are 24, 50, 165 and 215 nM for PI | ||||
| 160926011 | TG100-115 | 677297-51-7 | 98% by HPLC |  |
| TG100-115, inhibited PI3K and -(IC50 values of 83 and 235 nM, respectively), whereas | ||||
| 16071029 | Taltirelin | 103300-74-9 | 98% by HPLC |  |
| Taltirelin | ||||
| 16071020 | TMP-195 | 1314891-22-9 | 98% by HPLC |  |
| TMP-195 | ||||
| 16071003 | TC-G 1008 | 1621175-65-2 | 98% by HPLC |  |
| TC-G 1008, | ||||
| 16070909 | T-5224 | 530141-72-1 | 98% by HPLC |  |
| T-5224 is a selective inhibitor of c-Fos/activator protein-1. T-5224 ameliorates live | ||||